Functional analysis and case-control study of-160C/A polymorphism in the E-cadherin gene promoter:: Association with cancer risk

被引:0
|
作者
Cattaneo, Francesca
Venesio, Tiziana
Molatore, Sara
Russo, Antonio
Fiocca, Roberto
Frattini, Milo
Scovassi, A. Ivana
Ottini, Laura
Bertario, Lucio
Ranzani, Guglielmina Nadia
机构
[1] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy
[2] Inst Canc Res & Treatment, Unit Pathol, I-10060 Turin, Italy
[3] Local Hlth Author, Epidemiol Unit, I-20122 Milan, Italy
[4] Univ Genoa, Dept Surg & Morphol Sci, I-16132 Genoa, Italy
[5] CNR, Inst Mol Genet, I-27100 Pavia, Italy
[6] NCI, INT, I-20133 Milan, Italy
[7] Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy
关键词
CDH1; gene; promoter; polymorphism; epithelial cells; cancer risk;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: A C-A polymorphism within the CDH1 (E-cadherin) promoter seems to be associated with a reduced efficiency of gene transcription in vitro. Due to the crucial role of E-cadherin in epithelia, tissue-specific effect of C -> A change on CDH1 transcription was tested and a case-control study was performed on patients affected with epithelial tumors. Patients and Methods: The -178/+93 CDH1 region containing either C or A nucleotide was inserted upstream of the Luciferase reporter gene in the pGL-2 vector, and the construct activity was assessed by transient transfection assay in HeLa and HCT116 cells. Results: A significantly lower activity for pGL-2,4 was found compared to pGL-2C, both in HeLa (54% decrease) and in HCT116 (67% decrease) cells. Genotyping of 246 controls and 505 patients affected with breast, gastric, colorectal, cervical and endometrial cancers demonstrated an association between the A allele and an increased risk of colorectal, gastric and endometrial tumors (1.66-, 1.81- and 2.35-fold, respectively). Conclusion: Our data support the notion that the A allele may act as a low-penetrance cancer susceptibility gene.
引用
收藏
页码:4627 / 4632
页数:6
相关论文
共 50 条
  • [1] Association of the -160 C→A promoter polymorphism of E-cadherin gene with gastric carcinoma risk
    Wu, MS
    Huang, SP
    Chang, YT
    Lin, MT
    Shun, CT
    Chang, MC
    Wang, HP
    Chen, CJ
    Lin, JT
    CANCER, 2002, 94 (05) : 1443 - 1448
  • [2] Contribution of the -160C/A Polymorphism in the E-cadherin Promoter to Cancer Risk: A Meta-Analysis of 47 Case-Control Studies
    Wang, Lin
    Wang, Guiying
    Lu, Chenqi
    Feng, Bo
    Kang, Jiuhong
    PLOS ONE, 2012, 7 (07):
  • [3] E-cadherin gene C-160A promoter polymorphism and risk of colorectal cancer in a Turkish population
    Tuncel, H.
    Shimamoto, F.
    Budak, M.
    Erdamar, S.
    FEBS JOURNAL, 2012, 279 : 157 - 157
  • [4] The E-cadherin gene polymorphism -160C -> A and cancer risk: A Huge review and meta-analysis of 26 case-control studies
    Wang, Gui-Ying
    Lu, Chen-Qi
    Zhang, Rong-Mei
    Hu, Xiao-Hua
    Luo, Z. W.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (01) : 7 - 14
  • [5] A single nucleotide polymorphism in the E-cadherin gene promoter-160 C/A is associated with risk of nasopharyngeal cancer
    Ben Nasr, Hela
    Hamrita, Bechr
    Batbout, Mariem
    Gabbouj, Sallouha
    Bouaouina, Noureddine
    Chouchane, Lotfi
    Chahed, Karim
    CLINICA CHIMICA ACTA, 2010, 411 (17-18) : 1253 - 1257
  • [6] -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer
    Jonsson, BA
    Adami, HO
    Hägglund, M
    Bergh, A
    Göransson, I
    Stattin, P
    Wiklund, F
    Grönberg, H
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 348 - 352
  • [7] E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer
    Lin, J.
    Dinney, C. P.
    Grossman, H. B.
    Jhamb, M.
    Zhu, Y.
    Spitz, M. R.
    Wu, X.
    CLINICAL GENETICS, 2006, 70 (03) : 240 - 245
  • [8] The associations of an E-cadherin promoter polymorphism (C-160A) with bladder cancer risk and clinical outcomes
    Lin, Jie
    Wang, Yunfei
    Dinney, Colin P.
    Zhao, Hua
    Grossman, Barton H.
    Wu, Xifeng
    CANCER RESEARCH, 2006, 66 (08)
  • [9] E-cadherin polymorphism - 160 C/A and prostate cancer
    Hajdinjak, T
    Toplak, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 480 - 481